Annual EBITDA:
-$99.19M+$13.11M(+11.67%)Summary
- As of today, STOK annual EBITDA is -$99.19 million, with the most recent change of +$13.11 million (+11.67%) on December 31, 2024.
- During the last 3 years, STOK annual EBITDA has fallen by -$14.10 million (-16.58%).
- STOK annual EBITDA is now -1723.10% below its all-time high of -$5.44 million, reached on December 31, 2017.
Performance
STOK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$42.10M-$15.86M(-60.44%)Summary
- As of today, STOK quarterly EBITDA is -$42.10 million, with the most recent change of -$15.86 million (-60.44%) on September 30, 2025.
- Over the past year, STOK quarterly EBITDA has dropped by -$13.21 million (-45.72%).
- STOK quarterly EBITDA is now -137.49% below its all-time high of $112.32 million, reached on March 31, 2025.
Performance
STOK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$31.43M-$13.21M(-29.59%)Summary
- As of today, STOK TTM EBITDA is $31.43 million, with the most recent change of -$13.21 million (-29.59%) on September 30, 2025.
- Over the past year, STOK TTM EBITDA has increased by +$144.18 million (+127.87%).
- STOK TTM EBITDA is now -29.59% below its all-time high of $44.64 million, reached on June 30, 2025.
Performance
STOK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
STOK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.7% | -45.7% | +127.9% |
| 3Y3 Years | -16.6% | -60.5% | +131.8% |
| 5Y5 Years | -181.6% | -218.6% | +165.2% |
STOK EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -16.6% | +11.7% | -137.5% | at low | -29.6% | +127.6% |
| 5Y | 5-Year | -181.6% | +11.7% | -137.5% | at low | -29.6% | +127.6% |
| All-Time | All-Time | -1723.1% | +11.7% | -137.5% | at low | -29.6% | +127.6% |
STOK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$42.10M(-60.4%) | $31.43M(-29.6%) |
| Jun 2025 | - | -$26.24M(-123.4%) | $44.64M(+4.7%) |
| Mar 2025 | - | $112.32M(+995.2%) | $42.65M(+144.0%) |
| Dec 2024 | -$99.19M(+11.7%) | -$12.55M(+56.6%) | -$96.93M(+14.0%) |
| Sep 2024 | - | -$28.89M(-2.3%) | -$112.75M(-2.6%) |
| Jun 2024 | - | -$28.23M(-3.6%) | -$109.90M(+3.4%) |
| Mar 2024 | - | -$27.26M(+3.9%) | -$113.76M(-3.4%) |
| Dec 2023 | -$112.30M(-9.2%) | -$28.37M(-9.0%) | -$110.04M(-2.2%) |
| Sep 2023 | - | -$26.03M(+18.9%) | -$107.69M(+0.2%) |
| Jun 2023 | - | -$32.09M(-36.3%) | -$107.89M(-7.7%) |
| Mar 2023 | - | -$23.54M(+9.5%) | -$100.19M(+0.6%) |
| Dec 2022 | -$102.81M(-20.8%) | -$26.02M(+0.8%) | -$100.82M(-2.1%) |
| Sep 2022 | - | -$26.22M(-7.5%) | -$98.70M(-4.4%) |
| Jun 2022 | - | -$24.40M(-1.0%) | -$94.59M(-3.2%) |
| Mar 2022 | - | -$24.17M(-1.1%) | -$91.69M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$85.09M(-63.1%) | -$23.91M(-8.1%) | -$83.83M(-13.3%) |
| Sep 2021 | - | -$22.11M(-2.8%) | -$74.01M(-13.7%) |
| Jun 2021 | - | -$21.50M(-31.8%) | -$65.12M(-16.0%) |
| Mar 2021 | - | -$16.32M(-15.9%) | -$56.15M(-9.3%) |
| Dec 2020 | -$52.16M(-48.1%) | -$14.08M(-6.6%) | -$51.37M(-6.5%) |
| Sep 2020 | - | -$13.21M(-5.5%) | -$48.22M(-7.8%) |
| Jun 2020 | - | -$12.53M(-8.6%) | -$44.72M(-10.3%) |
| Mar 2020 | - | -$11.54M(-5.6%) | -$40.53M(-15.0%) |
| Dec 2019 | -$35.23M(-180.3%) | -$10.93M(-12.5%) | -$35.23M(-45.0%) |
| Sep 2019 | - | -$9.72M(-16.5%) | -$24.30M(-66.6%) |
| Jun 2019 | - | -$8.34M(-33.6%) | -$14.58M(-133.6%) |
| Mar 2019 | - | -$6.24M(-232.0%) | -$6.24M(-232.0%) |
| Dec 2018 | -$12.57M(-131.0%) | - | - |
| Mar 2018 | - | -$1.88M | -$1.88M |
| Dec 2017 | -$5.44M | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Stoke Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Stoke Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of STOK is -$99.19M
What is the all-time high annual EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual EBITDA is -$5.44M
What is Stoke Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, STOK annual EBITDA has changed by +$13.11M (+11.67%)
What is Stoke Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of STOK is -$42.10M
What is the all-time high quarterly EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly EBITDA is $112.32M
What is Stoke Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, STOK quarterly EBITDA has changed by -$13.21M (-45.72%)
What is Stoke Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of STOK is $31.43M
What is the all-time high TTM EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM EBITDA is $44.64M
What is Stoke Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, STOK TTM EBITDA has changed by +$144.18M (+127.87%)